CNBX Pharmaceuticals Inc. (CNBX) stock
CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $197.79KP/E –Yield –
CNBX Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
CNBX Pharmaceuticals's revenue for the twelve months ending May 31, 2026 was $0. For fiscal 2025 it was $0, down 100.0% from the year before. The highest annual figure on record is $410.17K in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $0 | -100.0% |
| FY2024 | Aug 31, 2024 | $130.07K | -68.3% |
| FY2023 | Aug 31, 2023 | $410.17K | +1269.1% |
| FY2022 | Aug 31, 2022 | $29.96K | – |
| FY2021 | Aug 31, 2021 | $0 | -100.0% |
| FY2020 | Aug 31, 2020 | $7.16K | -27.3% |
| FY2019 | Aug 31, 2019 | $9.84K | +2.5% |
| FY2018 | Aug 31, 2018 | $9.60K | +68.9% |
| FY2017 | Aug 31, 2017 | $5.68K | -94.9% |
| FY2016 | Aug 31, 2016 | $112.50K | – |
| FY2015 | Aug 31, 2015 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | May 31, 2026 | $0 | – |
| Q2 FY2026CQ1 2026 | Feb 28, 2026 | $0 | – |
| Q1 FY2026CQ4 2025 | Nov 30, 2025 | $0 | – |
| Q4 FY2025CQ3 2025 | Aug 31, 2025 | $0 | – |
| Q3 FY2025CQ2 2025 | May 31, 2025 | $0 | – |
| Q2 FY2025CQ1 2025 | Feb 28, 2025 | $0 | -100.0% |
| Q1 FY2025CQ4 2024 | Nov 30, 2024 | $0 | -100.0% |
| Q4 FY2024CQ3 2024 | Aug 31, 2024 | $0 | -100.0% |
| Q3 FY2024CQ2 2024 | May 31, 2024 | $0 | -100.0% |
| Q2 FY2024CQ1 2024 | Feb 29, 2024 | $40.64K | – |
| Q1 FY2024CQ4 2023 | Nov 30, 2023 | $89.44K | – |
| Q4 FY2023CQ3 2023 | Aug 31, 2023 | $100.00K | +233.8% |
| Q3 FY2023CQ2 2023 | May 31, 2023 | $310.17K | – |
| Q2 FY2023CQ1 2023 | Feb 28, 2023 | $0 | – |
| Q1 FY2023CQ4 2022 | Nov 30, 2022 | $0 | – |
| Q4 FY2022CQ3 2022 | Aug 31, 2022 | $29.96K | – |
| Q3 FY2022CQ2 2022 | May 31, 2022 | $0 | – |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | $0 | -100.0% |
| Q3 FY2021CQ2 2021 | May 31, 2021 | $0 | -100.0% |
| Q2 FY2021CQ1 2021 | Feb 28, 2021 | $0 | -100.0% |
| Q1 FY2021CQ4 2020 | Nov 30, 2020 | $0 | -100.0% |
| Q4 FY2020CQ3 2020 | Aug 31, 2020 | $2.21K | +7.2% |
| Q3 FY2020CQ2 2020 | May 31, 2020 | $1.89K | -12.7% |
| Q2 FY2020CQ1 2020 | Feb 29, 2020 | $1.31K | -43.5% |
| Q1 FY2020CQ4 2019 | Nov 30, 2019 | $1.75K | -46.9% |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | $2.06K | -30.4% |
| Q3 FY2019CQ2 2019 | May 31, 2019 | $2.16K | -26.9% |
| Q2 FY2019CQ1 2019 | Feb 28, 2019 | $2.32K | +20.1% |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | $3.31K | +88.0% |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | $2.96K | +3.0% |
| Q3 FY2018CQ2 2018 | May 31, 2018 | $2.96K | +88.2% |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | $1.93K | +55.3% |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | $1.76K | – |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | $2.87K | -94.3% |
| Q3 FY2017CQ2 2017 | May 31, 2017 | $1.57K | – |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | $1.24K | – |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | $0 | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | $50.00K | – |
See a number that looks wrong?